Skip to main content

Breast Cancer

Submissions from 2024 2024

A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2–positive breast cancer (TUTOR), Manmeet Ahluwalia, Ahmad Ozair, Mainak Bardhan, Dilanis Perche, Muni Rubens, Yazmin Odia, Rupesh Kotecha, Daniel Leon Ariza, Michael McDermott, Ana Cristina Sandoval Leon, Reshma Mahtani, Shreyas Bellur, and David Peereboom

An Overview of the Therapeutic Strategies for Neoplastic Meningitis due to Breast Cancer: When and Why?, Mainak Bardhan

Comparative survival analysis of patients with HER2-low and HER2-positive metastatic breast cancer with or without brain metastases treated with trastuzumab deruxtecan, Mainak Bardhan, Charlie Hurmiz, Mohammad Ganiyani, Reshma Mahtani, and Manmeet Ahluwalia

An Overview of the Therapeutic Strategies for Neoplastic Meningitis due to Breast Cancer: When and Why?, Mainak Bardhan, Ahmad Ozair, Reshma Mahtani, Yazmin Odia, and Manmeet Ahluwalia

HER2+ early breast cancer treatment and outcomes by risk of recurrence: a retrospective US electronic health records study, Reshma Mahtani

Multi-Institutional Quality Improvement on HER2-Positive and HER2-Low Metastatic Breast Cancer, Reshma Mahtani

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer, Reshma Mahtani

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer, Reshma Mahtani

The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results, Reshma Mahtani

Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series, Reshma Mahtani and Natasha Harpalani

Sequencing Sacituzumab Govitecan (SG) AfteR Trastuzumab Deruxtecan (T-DXd) In ER+/HER2 LOW MetaStatic Breast Cancer, Reshma Mahtani, Ana Cristina Sandoval Leon, Maria Abreu, and Manmeet Ahluwalia

Multicenter retrospective cohort study of the sequential use of antibody drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2 low metastatic breast cancer (MBC): a subgroup analysis of next generation sequencing results., Reshma Mahtani, Mehmet Zerey, Ana Cristina Sandoval Leon, Lauren Carcas, Joseph Panoff, and Manmeet Ahluwalia

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial, Minesh Mehta

Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial, Ana Sandoval Leon

Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial, Ana Sandoval-Leon

Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904), Ana Sandoval-Leon

Submissions from 2023 2023

Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from Her-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial, Manmeet Ahluwalia, Atulya Khosla, Ahmad Ozair, Rupesh Kotecha, Michael McDermott, Minesh Mehta, Ana Sandoval Leon, and Reshma Mahtani

CTNI-08: Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from HER-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial, Manmeet Ahluwalia, Ahmad Ozair, Atulya Khosla, Shreyas Bellur, Rupesh Kotecha, Michael McDermott, Minesh Mehta, Ana Cristina Sandoval Leon, and Reshma Mahtani

BPI23-011: Real-World Study of First-Line Treatment Patterns in HR+/HER2– Metastatic Breast Cancer (MBC) at a Tertiary Care Cancer Institute, Yolcar Chamorro, Manmeet Ahluwalia, Muni Rubens, Reshma Mahtani, and Ana Sandoval Leon

Outcomes among Hispanic metastatic breast cancer patients treated with alpelisib and fulvestrant: single institution retrospective study, Yolcar Chamorro, Reshma Mahtani, Shanada Monestime, Naomi Dempsey, Muni Rubens, Manmeet Ahluwalia, and Ana Sandoval Leon

Incidence and outcomes among patients with HR+/HER2- metastatic breast cancer (mBC) with co-occurring ESR1 and PIK3CA mutations detected by ctDNA and treated with alpelisib: A retrospective review., Yolcar Chamorro, Ana Sandoval Leon, Manmeet Ahluwalia, Reshma Mahtani, and Naomi Dempsey

Characterization of Physical Function and Cancer-Related Physical Impairments in Hispanic Women With Breast Cancer: A Descriptive Study, Adrian Cristian, Muni Rubens, Grace Wang, and Jane Mendez

Metastatic HER2‑Positive Breast Cancer: Is There an Optimal Sequence of Therapy?, Naomi Dempsey, Ana Sandoval Leon, and Reshma Mahtani

Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer, Reshma Mahtani

Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the United States, Europe, and Israel, Reshma Mahtani

Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial, Reshma Mahtani and Youssef Zeidan

Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trials, Joseph Panoff and Youssef Zeidan

Estimating the risk of developing hypothyroidism in comprehensive breast cancer patients with sensitivity analysis computed from patient-setup and proton-range uncertainties, Andrew Wroe, Marcio Fagundes, Minesh Mehta, Alonso Gutierrez, and Jen Yu

Posters from 2022 2022

Breast Cancer and Skin Reactions, Melanie Bello, Paola Colon, Nicole Llosa, Sabrina Perez-Borroto, and Sasha Valdes

Hyperglycemia in Hispanic MBC patients treated with alpelisib: single institution retrospective study, Yolcar Chamorro, Reshma Mahtani, Shanada Monestime, Manmeet Ahluwalia, Muni Rubens, and Ana Sandoval Leon

The Impact of Smaller Thyroid Gland Volume on the Risk of Developing Post-RT Hypothyroidism in Breast Cancer Patients Requiring Comprehensive Nodal Irradiation, Rupesh Kotecha, Tugce Kutuk, Andrew Wroe, Alonso Gutierrez, Minesh Mehta, and Marcio Fagundes

The Impact of Thyroid Gland Volume on the Risk of Developing Post-RT Hypothyroidism in Breast Cancer Patients Requiring Comprehensive Nodal Irradiation, Rupesh Kotecha, Andrew Wroe, Tugce Kutuk, Alonso Gutierrez, Minesh Mehta, and Marcio Fagundes

A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis, Reshma Mahtani

BRCA1/2 Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and Israel, Reshma Mahtani

Impact of genomic assays on treatment and outcomes in locally advanced breast cancer, Reshma Mahtani

Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel, Reshma Mahtani

Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2‒Negative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel, Reshma Mahtani

Asymptomatic syringomatous adenoma of the nipple: A rare nipple neoplasm, Starr Mautner, Katharine Lampen-Sachar, and Michaela Nguyen

Is breast conservation superior to mastectomy in early stage triple negative breast cancer?, Joseph Panoff

Effect of translational and rotational errors on NTCP and TCP in PBS proton plans for comprehensive breast cancer irradiation, Shyam Pokharel, Suresh Rana, and Michael Kasper

SWOG 1904: Cluster-randomized controlled trial of patient and provider decision support to increase chemoprevention informed choice among women with atypical hyperplasia or lobular carcinoma in situ (MiCHOICE), Ana Sandoval Leon

Submissions from 2021 2021

Correlation of tissue oxygenation and skin toxicity to determine the effectiveness of photon vs proton therapy in breast cancer subjects, Corina Beiner, Maria-Amelia Rodrigues, Marcio Fagundes, Joseph Panoff, and Michael Chuong

Intramedullary rod failure in metastatic breast cancer: Do triple negative cancer patients have more revision surgery?, Ana Cecilia Belzarena Genovese

Shoulder Dysfunction in Breast Cancer, Adrian Cristian

Proton Therapy for Breast Cancer: A Consensus Statement from the Particle Therapy Cooperative Group (PTCOG) Breast Cancer Subcommittee, Marcio Fagundes

Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance, Rupesh Kotecha, Raees Tonse, Muni Rubens, Michael McDermott, Yazmin Odia, Haley Appel, and Minesh Mehta

Invasive Paget's Disease of the Breast: Rash or Recurrence?, Starr Mautner, Niloofar Nasseri-Nik, Katharine Lampen-Sachar, and Austin Pourmoussa

Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis, Ana Sandoval Leon

Systemic Therapy for the Treatment of Breast Cancer, Ana Cristina Sandoval Leon

Eribulin Plus Pembrolizumab in Patients With Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase 1b/2 Study, Grace Wang

Impact of Dose Calculation Algorithm on Skin Dose for Breast Cancer Treated With Intensity Modulated Proton Therapy, Jen Yu, Andrew Wroe, Lian Acosta, Marcio Fagundes, Pouya Sabouri, Joseph Panoff, Maria-Amelia Rodrigues, Jessika Contreras, Minesh Mehta, and Alonso Gutierrez

Submissions from 2020 2020

Tissue Oxygenation Changes in Response to Radiation Therapy in Breast Cancer Subjects Using Near-Infrared Optical Imaging, Corina Beiner, Maria-Amelia Rodrigues, and Michael Chuong

Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today, John Bryant, Michael Chuong, and Minesh Mehta

Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival, John Bryant, Michael Chuong, and Minesh Mehta

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial, Lauren Carcas

Pain Control in Breast Surgery: Survey of Current Practice and Recommendations for Optimizing Management-American Society of Breast Surgeons Opioid/Pain Control Workgroup, Starr Mautner

Reconstructive Surgery and Postoperative Care for Breast Cancer, Miguel Medina and Harry Salinas

Breast Cancer Surgery, Jane Mendez

Standardized Risk Assessment and Risk-Stratified Venous Thromboembolism Prophylaxis for Patients Undergoing Breast Operation, Jane Mendez

Principles of Radiation Therapy in Breast Cancer, Maria-Amelia Rodrigues

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study, Miguel Villalona Calero

Presence and Distress of Chemotherapy-Induced Peripheral Neuropathy Symptoms in Upper Extremities of Younger and Older Breast Cancer Survivors, Noah Zanville

Submissions from 2019 2019

Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis, Rupesh Kotecha

Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases, Rupesh Kotecha

Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans, Suresh Rana and Jaafar Bennouna

Submissions from 2018 2018

A parallel model for breast cancer metastasis, Jeffrey Boyd

(OA13) Stereotactic Radiosurgery and Concurrent Targeted Therapy: Improving the Response Rate for Breast Cancer Brain Metastasis, Rupesh Kotecha

Benchmarking the American Society of Breast Surgeon Member Performance for More Than a Million Quality Measure-Patient Encounters, Starr Mautner

Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely® Campaign, Starr Mautner

Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer, Minesh Mehta

Submissions from 2017 2017

Changing Dogma and Decreased Collateral Damage in Breast Cancer Care, Jane Mendez

Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions, Jane Mendez

Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options, Jane Mendez

Submissions from 2016 2016

Postsurgical Depressive Symptoms and Proinflammatory Cytokine Elevations in Women Undergoing Primary Treatment for Breast Cancer, Robert Derhagopian

Postsurgical Depressive Symptoms and Proinflammatory Cytokine Elevations in Women Undergoing Primary Treatment for Breast Cancer, Robert Derhagopian

Measures of Appropriateness and Value for Breast Surgeons and Their Patients: The American Society of Breast Surgeons Choosing Wisely ® Initiative, Starr Mautner

Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer, Minesh Mehta

Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial, Miguel Villalona Calero